Establishment of a new valid animal model for the evaluation of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric rhabdomyosarcoma
Benedikt R. Wagner1*, +, Anna L. Adamus1+, Dörthe Sönnecken1, Reza Vahdad1, Paul Jank2, Carsten Denkert2, Andreas H. Mahnken3, 4, Guido Seitz1
1 Department of Pediatric Surgery, University Hospital Marburg, Baldingerstrasse,
35033 Marburg, Germany.
2 Department of Pathology, University Hospital Marburg, Baldingerstrasse, 35033
Marburg, Germany.
3 Department of Radiology, University Hospital Marburg, Baldingerstrasse, 35033
Marburg, Germany.
4 Center for Tumor Biology and Immunology, Core Facility for Small Animal MRI,
Hans-Meerwein Str. 3, 35043 Marburg, Germany.
+ Dres. Wagner and Adamus contributed equally to the first authorship of this paper.
* Corresponding author:
Benedikt Wagner, Department of Pediatric Surgery, University Hospital Marburg,
Baldingerstrasse, 35033 Marburg, Germany.
Tel.: +49 (0) 6421/58-66226
Email: bwagner@med.uni-marburg.de
The content the abstract of this paper had been previously published as a meeting abstract.11Wagner B, Adamus A, Mahnken A, Jank P, Denkert C, Seitz G (2020): A new valid animal model for the evaluation of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric rhabdomyosarcoma. Pediatric Blood & Cancer, Volume67, IssueS4 Supplement: Abstracts from the 52th Congress of the International Society of Paediatric Oncology (SIOP) Virtual Congress, October 14–17, 2020, December 2020, e28742, SIOP Abstracts 2020, Abstract No. 0213 / #487, 13 October 2020, https://doi.org/10.1002/pbc.28742
Word Count for:
a) Abstract: 249
b) Main Text: 3.040
The number of:
a) Tables: 1
b) Figures: 5
c) Supporting Information files: 1
Running title
HIPEC animal model for rhabdomyosarcoma